TABLE 2

Pharmacological and non-pharmacological treatment for patients with relapsing polychondritis

Patient	Sex	Age years	CPAP	Stent	IS drugs	Corticosteroid dose	Previous drugs	Baseline RPDAI
1	M	65	N	N	MTX		Pred	37
2	F	70	N	N	MMF, infliximab	Pred 5 mg	SSZ	27
3	F	50	DNT	N	MTX		Pred	45
4	F	53	Y	Y	MMF, MTX	Pred 10 mg	AZA, cyclophosphamide, ADA and ETN	47
5	F	76	Y	N	SSZ, HCQ, ABT, IVIG	Pred 7.5 mg	MTX, ETN, leflunomide, AZA	44
6	F	74	Y	Y	MTX, AZA	Pred 10 mg	Cyclophosphamide	43
7	F	76	Y	N	Cyclophosphamide	Pred 10 mg	MTX	27
8	F	70	N	N	AZA	Pred 5 mg		15
9	F	78	DNT	N		Pred 5 mg	MTX, AZA, HCQ	24
10	M	31	N	N		HCT 20/10/10		33
11	F	52	N	N	Secukinumab	Pred 10 mg	MTX, ETN, HCQ, cyclophosphamide, ADA	38
12	M	79	N	N		Pred 5 mg		35
13	M	78	Y	Y	MTX	Pred 5 mg	AZA	40

CPAP: continuous positive airway pressure; IS: immunosuppressant; RPDAI: Relapsing Polychondritis Activity Index; MTX: methotrexate; Pred: prednisolone; MMF: mycophenolate mofetil; SSZ: sulfasalazine; DNT: did not tolerate; AZA: azathioprine; ETN: etanercept; HCQ: hydroxychloroquine; ABT: abatacept; IVIG: intravenous immunoglobulin; HCT: hydrocortisone; ADA: adalimumab.